Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
2 competitors in Geographic Atrophy Secondary to Age-related Macular Degeneration
View Full LandscapeTarget Indication
Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical Trial
NCT04770545Last updated: 12/4/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Syfovre
Treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
View on EMAAspaveli
Aspaveli is indicated as monotherapy in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia.